87073-110 : Rapiblyk 280 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 87073-110
Labeler: Aop Health Us, LLC
Product Type: Human Prescription Drug
Drug Name:  Rapiblyk
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA217202
Rev. Date: 


NDC Package Codes:

  • 87073-110-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (87073‑110‑01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Landiolol Hydrochloride

Dosage Strength:

  • 280 mg

Pharmaceutical Classes:

  • Adrenergic beta1-Antagonists [MoA]
  • beta-Adrenergic Blocker [EPC]

Related Products:

Based on records with the same trade name.
  • 84381-110 Rapiblyk 280 mg Intravenous Injection, Powder, Lyophilized, for Solution by Aop Orphan Pharmaceuticals Gmbh

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 87073-110 QR Code

< Prev: 87069-462Next: 87075-001 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.